Monday, 14 September 2026European Markets

SIPEF, SAVENCIA, Another 2 Companies Have A High Dividend Yield And Return On Equity In The Consumer Defensive Sector.

Loading stream...

(vianews) - sipef (sip.br) is among this list of stock assets with the highest dividend rate and return on equity on the consumer defensive sector.

financial asset price forward dividend yield return on equity
sipef (sip.br) €55.00 5.58% 9.39%
savencia (save.pa) €55.40 2.37% 4.84%
j.martins,sgps (jmt.ls) €23.84 2.32% 28.68%
remy cointreau (rco.pa) €149.95 1.37% 17.18%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. sipef (sip.br)

5.58% forward dividend yield and 9.39% return on equity

sipef nv operates as an agro-industrial company. it operates through palm, rubber, tea, and bananas and plants segments. the company offers crude palm oil, palm kernels, and palm kernel oil; ribbed smoked sheets, and scraps and lumps; cut, tear, and curl tea; and bananas and plants from ivory coast. it has operations in indonesia, papua new guinea, ivory coast, singapore, europe, and internationally. the company was incorporated in 1919 and is headquartered in schoten, belgium.

earnings per share

as for profitability, sipef has a trailing twelve months eps of €6.79.

pe ratio

sipef has a trailing twelve months price to earnings ratio of 8.1. meaning, the purchaser of the share is investing €8.1 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.39%.

volume

today's last reported volume for sipef is 798 which is 60.63% below its average volume of 2027.

yearly top and bottom value

sipef's stock is valued at €55.00 at 02:30 est, way below its 52-week high of €66.20 and higher than its 52-week low of €51.70.

more news about sipef.

2. savencia (save.pa)

2.37% forward dividend yield and 4.84% return on equity

savencia sa produces, distributes, and markets dairy and cheese products in france, rest of europe, and internationally. it offers cheese, butters, creams, and dairy ingredients and nutritional solutions for the retail market and foodservices market. the company provides its products under the caprice des dieux, saint albray, le rustique, cœur de lion, saint agur, bresse bleu, pdo roquefort papillon, st-morêt, tartare, carré frais, apérivrais, chavroux, saint-loup, richesmonts raclette, géramont, saint albray, fol epi, bresso, milkana, brunch, burgo de arias, ile de france, milkaut, santa rosa, delaco, kral syru, lucina, král sýru, medve, alouette, rogue creamery, polenghi, corman, balade, and elle & vire brands. the company was formerly known as bongrain sa and changed its name to savencia sa in april 2015.savencia sa was founded in 1956 and is headquartered in viroflay, france. savencia sa is a subsidiary of savencia holding sca.

earnings per share

as for profitability, savencia has a trailing twelve months eps of €5.01.

pe ratio

savencia has a trailing twelve months price to earnings ratio of 11.06. meaning, the purchaser of the share is investing €11.06 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.84%.

more news about savencia.

3. j.martins,sgps (jmt.ls)

2.32% forward dividend yield and 28.68% return on equity

jerónimo martins, sgps, s.a. operates in the food distribution and specialized retail sectors in portugal, poland, and colombia. the company operates through portugal retail; portugal cash & carry; poland retail; colombia retail; and others, eliminations and adjustments segments. it operates food stores under the biedronka name; and a chain of health and beauty stores under the hebe banner in poland, as well as food stores under the ara name in colombia. the company also operates supermarkets under the pingo doce banner; and cash and carry stores under the recheio name in portugal. in addition, it operates restaurants under the pingo doce name; bem-estar pharmacies; petrol stations; and clothing under code brand. further, the company operates kiosks and coffee shops under the jeronymo name; and chocolates and confectionary retail stores under hussel name. additionally, the company engages in human resources top management, real estate management and administration, training, and saline brackish waters aquaculture; wholesale of fruit and vegetables; retail management, consultancy, and logistics activities; the purchase and sale of real estate; growing of crops and farming of animals; retail sale of health and beauty products; manufacture of milk and dairy products; and provision of economic and accounting, business portfolio management, financial, and sea passenger water transport services. it is also involved in the trading and distribution of consumer goods; retail and wholesale of non-food products; other business support service activities; and provision of services in the area of wholesale and retail distribution. the company was founded in 1792 and is headquartered in lisbon, portugal. jerónimo martins, sgps, s.a. is a subsidiary of sociedade francisco manuel dos santos, sgps, s.e.

earnings per share

as for profitability, j.martins,sgps has a trailing twelve months eps of €1.02.

pe ratio

j.martins,sgps has a trailing twelve months price to earnings ratio of 23.37. meaning, the purchaser of the share is investing €23.37 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.68%.

revenue growth

year-on-year quarterly revenue growth grew by 21%, now sitting on 28.01b for the twelve trailing months.

earnings before interest, taxes, depreciation, and amortization

j.martins,sgps's ebitda is 33.41.

more news about j.martins,sgps.

4. remy cointreau (rco.pa)

1.37% forward dividend yield and 17.18% return on equity

rémy cointreau sa, together with its subsidiaries, engages in the production, sale, and distribution of liqueurs and spirits. the company operates through rémy martin, liqueurs & spirits, and partner brands segments. it offers liqueurs, brandy, gin, single malt whisky, rum, wine, and champagne primarily under the cointreau, metaxa, st-rémy, mount gay, bruichladdich, port charlotte, octomore, the botanist, westland, louis xiii, and domaine des hautes glaces brands. the company operates in europe, the middle east, africa, the americas, asia, australia, and new zealand. rémy cointreau sa was founded in 1724 and is headquartered in cognac, france.

earnings per share

as for profitability, remy cointreau has a trailing twelve months eps of €5.7.

pe ratio

remy cointreau has a trailing twelve months price to earnings ratio of 26.31. meaning, the purchaser of the share is investing €26.31 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.18%.

more news about remy cointreau.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,285 source documents archived
Query this data → isubstrate.com